Business Description
Silo Pharma Inc. is a Florida-based biopharmaceutical company focused on developing new treatments for conditions that currently have few good medical options, including PTSD, fibromyalgia, Alzheimer's disease, and multiple sclerosis. Its pipeline includes both conventional and psychedelic-based therapies delivered through innovative methods such as nasal sprays and slow-release implants. The company conducts its research in partnership with leading academic institutions, including Columbia University and the University of Maryland Baltimore.
